{"id":"NCT02913326","sponsor":"Boehringer Ingelheim","briefTitle":"A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)","officialTitle":"RE-SPECT CVT: a Randomised, Open-label, Exploratory Trial With Blinded Endpoint Adjudication (PROBE), Comparing Efficacy and Safety of Oral Dabigatran Etexilate Versus Oral Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis Over a 24-week Period","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-13","primaryCompletion":"2018-06-22","completion":"2018-06-22","firstPosted":"2016-09-23","resultsPosted":"2019-08-15","lastUpdate":"2019-08-15"},"enrollment":120,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Thromboembolism"],"interventions":[{"type":"DRUG","name":"Dabigatran etexilate","otherNames":[]},{"type":"DRUG","name":"Warfarin","otherNames":[]}],"arms":[{"label":"Dabigatran etexilate","type":"EXPERIMENTAL"},{"label":"Warfarin","type":"ACTIVE_COMPARATOR"}],"summary":"This is a multi-center, prospective, international, randomized (1:1), open-label study with two parallel groups. This phase III study is planned to investigate the efficacy and safety of dabigatran etexilate versus dose-adjusted warfarin on a net clinical benefit endpoint of major bleeding (ISTH criteria) and new venous thrombotic event (VTE) (primary endpoint) with blinded endpoint adjudication.","primaryOutcome":{"measure":"Percentage of Participants With Composite of Venous Thrombotic Event (VTE) or Major Bleeding Event (MBE) According to International Society on Thrombosis and Haemostasis (ISTH) Criteria in Full Observation Period.","timeFrame":"From first administration of trial medication until 6 days after last administration of trial medication, up to 25 weeks.","effectByArm":[{"arm":"Dabigatran Etexilate","deltaMin":1.7,"sd":null},{"arm":"Warfarin","deltaMin":3.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":36,"countries":["France","Germany","India","Italy","Netherlands","Poland","Portugal","Russia","Spain"]},"refs":{"pmids":["33724104","32972315","31479105","29775170"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":60},"commonTop":["Headache","Diarrhoea","Depression","Cough","Dyspepsia"]}}